These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1744924)

  • 1. Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously.
    Priest DG; Schmitz JC; Bunni MA; Stuart RK
    J Natl Cancer Inst; 1991 Dec; 83(24):1806-12. PubMed ID: 1744924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of tetrahydrofolates in human plasma after leucovorin administration.
    Bunni MA; Rembiesa BM; Priest DG; Sahovic E; Stuart R
    Cancer Chemother Pharmacol; 1989; 23(6):353-7. PubMed ID: 2785439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of leucovorin and its metabolites in dietary folic acid-deplete mice - comparison between tumor, liver, and plasma.
    Raghunathan K; Schmitz JC; Priest DG
    Cancer Chemother Pharmacol; 1997; 40(2):126-30. PubMed ID: 9182833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of folic acid and its metabolites: a comparison with leucovorin.
    Schmitz JC; Stuart RK; Priest DG
    Clin Pharmacol Ther; 1994 May; 55(5):501-8. PubMed ID: 8181194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration.
    Schilsky RL; Ratain MJ
    J Natl Cancer Inst; 1990 Sep; 82(17):1411-5. PubMed ID: 2388292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Rodman JH; Maneval DC; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jun; 50(12):3493-502. PubMed ID: 2140289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of reduced folate changes to inhibition of DNA synthesis induced by methotrexate in L1210 cells in vivo.
    Priest DG; Bunni M; Sirotnak FM
    Cancer Res; 1989 Aug; 49(15):4204-9. PubMed ID: 2743307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical stability and human plasma pharmacokinetics of reduced folates.
    Odin E; Carlsson G; Frösing R; Gustavsson B; Spears CP; Larsson PA
    Cancer Invest; 1998; 16(7):447-55. PubMed ID: 9774951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of leucovorin and its metabolites in the plasma, intestinal epithelium, and intraperitoneal L1210 cells of methotrexate-pretreated mice.
    Bunni MA; Sirotnak FM; Otter GM; Priest DG
    Cancer Chemother Pharmacol; 1994; 34(6):455-8. PubMed ID: 7923554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of leucovorin (D,L-5-formyltetrahydrofolate) after intravenous injection and constant intravenous infusion.
    Straw JA; Newman EM; Doroshow JH
    NCI Monogr; 1987; (5):41-5. PubMed ID: 3501545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of leucovorin calcium after intravenous, intramuscular, and oral administration.
    McGuire BW; Sia LL; Leese PT; Gutierrez ML; Stokstad EL
    Clin Pharm; 1988 Jan; 7(1):52-8. PubMed ID: 3257913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption kinetics of orally administered leucovorin calcium.
    McGuire BW; Sia LL; Haynes JD; Kisicki JC; Gutierrez ML; Stokstad EL
    NCI Monogr; 1987; (5):47-56. PubMed ID: 3501546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence of two leucovorin calcium tablet formulations.
    De Vito JM; McGuire BW; De Lap RJ; Weiss AI
    DICP; 1989 Feb; 23(2):153-4. PubMed ID: 2786292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts.
    Houghton JA; Schmidt C; Houghton PJ
    Eur J Cancer Clin Oncol; 1982 Apr; 18(4):347-54. PubMed ID: 6889511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma.
    Trave F; Rustum YM; Petrelli NJ; Herrera L; Mittelman A; Frank C; Creaven PJ
    J Clin Oncol; 1988 Jul; 6(7):1184-91. PubMed ID: 3260621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma kinetic study following oral administration of leucovorin tablets in patients with gastric cancer--influence of subtotal gastrectomy].
    Nashimoto A; Sasaki J; Akai S; Sato T; Inada S
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3747-54. PubMed ID: 2596859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients.
    Damle B; Ravandi F; Kaul S; Sonnichsen D; Ferreira I; Brooks D; Stewart D; Alberts D; Pazdur R
    Clin Cancer Res; 2001 Mar; 7(3):517-23. PubMed ID: 11297242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence of oral and injectable levoleucovorin and leucovorin.
    DeVito JM; Kozloski GD; Tonelli AP; Johnson JB
    Clin Pharm; 1993 Apr; 12(4):293-9. PubMed ID: 8458180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin.
    Pazdur R
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):35-9. PubMed ID: 9348565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancer.
    Mader RM; Steger GG; Rizovski B; Sieder AE; Locker G; Gnant MF; Jakesz R; Rainer H
    Br J Clin Pharmacol; 1994 Mar; 37(3):243-8. PubMed ID: 8198932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.